John C Martin - Net Worth and Insider Trading
John C Martin Net Worth
The estimated net worth of John C Martin is at least $190 Million dollars as of 2024-04-28. John C Martin is the Director of Gilead Sciences Inc and owns about 2,877,762 shares of Gilead Sciences Inc (GILD) stock worth over $188 Million. John C Martin is also the Director of Kronos Bio Inc and owns about 1,952,364 shares of Kronos Bio Inc (KRON) stock worth over $2 Million. Details can be seen in John C Martin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John C Martin has not made any transactions after 2020-10-14 and currently still holds the listed stock(s).
Transaction Summary of John C Martin
John C Martin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John C Martin owns 3 companies in total, including Kronos Bio Inc (KRON) , Sarepta Therapeutics Inc (SRPT) , and Gilead Sciences Inc (GILD) .
Click here to see the complete history of John C Martin’s form 4 insider trades.
Insider Ownership Summary of John C Martin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRON | Kronos Bio Inc | 2020-10-14 | director |
| SRPT | Sarepta Therapeutics Inc | 2020-01-13 | director |
| GILD | Gilead Sciences Inc | 2018-12-03 | director & Chairman and CEO |
John C Martin Latest Holdings Summary
John C Martin currently owns a total of 2 stocks. Among these stocks, John C Martin owns 2,877,762 shares of Gilead Sciences Inc (GILD) as of December 3, 2018, with a value of $188 Million and a weighting of 98.97%. John C Martin also owns 1,952,364 shares of Kronos Bio Inc (KRON) as of October 14, 2020, with a value of $2 Million and a weighting of 1.03%.
Latest Holdings of John C Martin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GILD | Gilead Sciences Inc | 2018-12-03 | 2,877,762 | 65.42 | 188,263,190 |
| KRON | Kronos Bio Inc | 2020-10-14 | 1,952,364 | 1.00 | 1,952,364 |
Holding Weightings of John C Martin
John C Martin Form 4 Trading Tracker
According to the SEC Form 4 filings, John C Martin has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 50,000 shares on December 3, 2018, which brought John C Martin around $4 Million.
According to the SEC Form 4 filings, John C Martin has made a total of 1 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kronos Bio Inc is the acquisition of 75,800 shares on October 14, 2020, which cost John C Martin around $1 Million.
Insider Trading History of John C Martin
- 1
John C Martin Trading Performance
GuruFocus tracks the stock performance after each of John C Martin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John C Martin is 1.24%. GuruFocus also compares John C Martin's trading performance to market benchmark return within the same time period. The performance of stocks bought by John C Martin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John C Martin's insider trading performs compared to the benchmark.
Performance of John C Martin
Average Return
-47.99%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.66 | 1.24 | -30.28 | -47.99 | -70.01 | -68.47 |
| Relative Return to S&P 500(%) | -14.43 | -7.56 | -48.51 | -75.21 | -71.35 | -75.93 |
John C Martin Ownership Network
Ownership Network List of John C Martin
Ownership Network Relation of John C Martin
John C Martin Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
John C Martin is the director of Kronos Bio Inc. Other key executives at Kronos Bio Inc include COO & General Counsel Barbara Kosacz , Chief Scientific Officer Christopher Dinsmore , and Chief Medical Officer & VP Jorge Dimartino .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, John C Martin made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 69,004 shares made by Jorge Dimartino , a net sale of 39,461 shares made by Christopher Dinsmore , and a net sale of 18,643 shares made by Yasir B. Al-wakeel .
In summary, during the past 3 months, insiders sold 31,509 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 31,509 shares. During the past 18 months, 169,293 shares of Kronos Bio Inc (KRON) were sold and 1,731,056 shares were bought by its insiders, resulting in a net purchase of 1,561,763 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
John C Martin Mailing Address
Above is the net worth, insider trading, and ownership report for John C Martin. You might contact John C Martin via mailing address: 333 Lakeside Drive, Foster City X1 94404.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
